Mechanistically, we showed that both knockdown of PTTG1 expression and simvastatin treatment potently attenuated breast cancer cell invasion, presumably through inhibition of the expression of PTTG1 downstream target genes, such as MMP-2, MMP9, c-myc, FGF-2, and cyclin D3. The gene discussed is FGF2; the disease is breast cancer.